Interleukin-1 receptor antagonist in head and neck squamous cell carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 122, Issue 7, 1996, Pages 751-759

  Von Biberstein, S Elizabeth ^a   Spiro, Jeffrey D ^a   Lindquist, Richard ^a   Kreutzer, Donald L ^a,b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MALE; METASTASIS; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

EID: 0030008942     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.1996.01890190047012     Document Type: Article

References (23)

1. Heo DS, Snyderman D, Gollin SM, et al. Biology, cytogenetics, and sensitivity to immunological effect cells of new head and neck squamous cell carcinoma cell lines. Cancer Res. 1987;47:6355-6362.
2. Boscia R, Chan K, Johnson JT, et al. Evaluation of therapeutic potential of interleukin-α expanded tumor-infiltrating lymphocytes in squamous cell carcinomas of the head and neck. Ann Otol Rhinol Laryngol. 1988;97:414-421.
3. Falkman J. Angiogenesis and breast cancer. J Clin Oncol. 1994;12:441-443.
4. Cohen RF, Contrino J, Spiro JD, Mann EA, Chen LL, Kreutzer DL. Interleukin 8 expression by head and neck squamous cell carcinoma. Arch Otolaryngol. 1994;121:202-209
5. Sica A, Matsushuma K, Van Damme J, et al. IL1 transcriptionally activates the neutrophil chemotactic factor IL8 gene in endothelial cells. Immunology. 1990; 69:548-553.
6. Arend WP. Interleukin-1 receptor antagonist. Adv Immunol. 1993;54:167-227.
7. Hyams JS, Fitzgerald JE, Wyzga N, et al. Relationship of interleukin-1 receptor antagonist to mucosal inflammation in inflammatory bowel disease. Dig Dis Sci. 1994;39:1893-1899.
8. Smith DR, Kunkel SL, Standiford TJ, et al. The production of interleukin-1 receptor antagonist by human bronchogenic carcinoma. Am J Pathol. 1993;143: 794-803.
9. Kline JN, Schwartz DA, Monick MM, Floerchinger CS, Hunninghake GW. Relative release of interleukin-1β and interleukin-1 receptor antagonist by alveolar macrophages. Chest. 1993;104:47-53.
10. Mann EA, Spiro JO, Chen LL, Kreutzer DL. Cytokine expression in head and neck squamous cell carcinomas. Am J Surg. 1992;164:567-573.
11. Dvorak HF. Abnormalities of hemostasis in malignant disease. In: Colman RW, Hirsh J, eds. Hemostasis and Thrombosis. Philadelphia, Pa: JB Lippincott Co; 1994:1238-1254.
12. Guo M, Rabin BS, Johnson JT, Paradis IL. Lymphocyte phenotyes at tumor margins in patients with head and neck cancer. Head Neck Surg. 1987;9:265-271.
13. Boheim K, Denz H, Boheim C, Glassl H, Giber H. Immunohistologic study of the distribution and status of activation of head and neck tumor infiltrating leukocytes. Arch Otorhinolaryngol. 1987;244:127-132.
14. Wolf GT, Hudson JL, Petoson KA, Miller HL, McClatchey KD. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis. Otolaryngol Head Neck Surg. 1986; 95:142-152.
15. Schadendrof D, Moller A, Algermissen B, Worm M, Sticherling M, Czarnetzki BM. IL-8 produced by human malignant melanoma cells in vitro is an essential growth factor. J Immunol. 1993;151:2667-2675.
16. Smith DR, Polverini PJ, Kunkel SL, et al. Inhibition of IL8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med. 1994;179:1409-1415.
17. Baggiolini M, Dewald B, Moser B. IL-8 and related chemotactic cytokines: CXC and CC chemokines. Adv Immunol. 1994;55:97-179.
18. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood. 1991;77:1627-1652.
19. Dinarello CA. Blocking interleukin-1 in disease. Blood Purif. 1993;11:118-127.
20. Vigers GPA, Caffes P, Evans RJ, Thompson RC, Eisenberg SP, Brandhuber BJ. X-ray structure of interleukin-1 receptor antagonist at 2.0-Å resolution. J Biol Chem. 1994;269:12874-12879.
21. Granowitz EV, Clark BD, Mancilla J, Dinarello CA. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J Biol Chem. 1991;266:14147-14150.
22. Miller LC, Lynch EA, Isa S, Logan JW, Dinarello CA, Steere AC. Balance of synovial fluid IL-1β and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet. 1993;1:146-147.
23. Maxwell K, Leonard G, Kreutzer DL. Cytokine regulation in otitis media with effusion: interleukin-1 receptor antagonist. Laryngoscope. In press.